was administered, if available.
(6) The amount of emergency opioid antagonist
administered, if available.
(7) Whether the drug-related overdose event resulted in
death.
(8) The suspected or confirmed drug involved in the
drug-related overdose event.
(c) Frequency.--A first responder agency or hospital
emergency department shall submit all information required under
subsection (b) to the program no later than 72 hours after a
drug-related overdose event was reported.
(d) Definition.--As used in this section, the term
"emergency opioid antagonist" means a medication approved by the
United States Food and Drug Administration to reverse the
effects of an opioid drug.
Section 7.2. Requirements for coroners and medical examiners.
(a) Submission.--A county coroner or medical examiner in
this Commonwealth shall electronically submit data, in the
format published under subsection (c), on a drug-related
overdose death to the department within five business days of
finalizing the cause and manner of the drug-related overdose
death.
(b) Contents of data.--In complying with subsection (a), a
county coroner or medical examiner shall provide all of the
following information to the department:
(1) Demographic information of the decedent, including
but not limited to, the full name, address and date of birth
of the decedent.
(2) The toxicology report.
(3) The autopsy report.
(4) The circumstances of the drug-related overdose
death.
(c) Publication.--The department shall transmit a notice of
the format for data submission under subsection (a) to the
Legislative Reference Bureau for publication in the Pennsylvania
Bulletin within 30 days of the effective date of this
subsection.
(d) Public reports.--The department shall use the data
submitted under subsection (a) to compile publicly available
reports containing statistics and patterns relating to drug-
related overdose deaths on a quarterly basis to help identify
threats to public health and safety.
(e) Liability.--Any individual who, in good faith, provides
data to the department under this section shall not be subject
to any civil or criminal liability as a result of providing the
data.
Section 6. Section 9 heading of the act is amended to read:
Section 9. Access to prescription information and drug-related
overdose event information.
* * *
2019/90AJB/HB1005A01645 - 4 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50